🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Castle Biosciences, Inc.

Castle Biosciences, Inc. logo
Market Cap: Medium
Employees: Medium

Decision Dx-Melanoma

Castle Biosciences, Inc. is a commercial-stage diagnostics company providing diagnostic and prognostic testing services for dermatological cancers, including products like Decision Dx-Melanoma for invasive cutaneous melanoma and other proprietary GEP tests.

Tags: dermatological cancers, diagnostics, metastasis risk, multi-gene expression profile, squamous cell carcinoma, uveal melanoma

Symbol: CSTL

Recent Price: $26.66

Industry: Medical - Diagnostics & Research

CEO: Mr. Derek J. Maetzold

Sector: Healthcare

Employees: 710

Address: 505 South Friendswood Drive, Friendswood, TX 77546

Phone: 866 788 9007

Leadership

  • Derek Maetzold, Founder, President, CEO and Director
  • Frank Stokes, Chief Financial Officer
  • Kristen Oelschlager, CHIEF OPERATING OFFICER
  • Toby Juvenal, CHIEF COMMERCIAL OFFICER
  • Sherri Borman, Ph.D., Executive Laboratory Director
  • John Abbott, VICE PRESIDENT, FINANCE
  • Rebecca Critchley-Thorne, Ph.D., vice president, research & development
  • Jay Braxton, Pharm.D., Vice President, Marketing and brand manager, uveal melanoma (um)
  • Hillary Caruso, Ph.D., Vice President, Strategic Operations
  • John Cheneval, Executive Director, Business Development
  • Kevin Doman, Vice President, Sales
  • Vicki Fish, Vice President, Skin Cancer Marketing
  • Matthew Goldberg, M.D., Senior vice president, medical
  • Keli Greenberg, Vice President, Human Resources
  • Alice Izzo, Vice President, regulatory and government affairs
  • Clare Johnson, R.N., Vice President, Clinical Research
  • Michael Maltby, Executive Director, Managed Care
  • Noreen Manning, Vice President, Reimbursement
  • Chris Otte, Vice President, Information Technology
  • Trisha Poteet, Vice President, Clinical Services
  • Camilla Zuckero, Vice President, Investor Relations & Corporate Affairs
  • Daniel Bradbury, Board Chairman
  • Kimberlee Caple, Director
  • G. Bradley Cole, Director
  • Rodney Cotton, Director
  • Ellen Goldberg, Director
  • Miles Harrison, Director
  • Tiffany Olson, Director

Last updated: 2024-12-31